Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01853644
Title Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Tivozanib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Chicago Illinois 60611 United States Details
CDH-Delnor Health System - Northwestern Medicine Cancer Center Warrenville Illinois 60555 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field